BEN
57
2
LB
33
2
HP
41
3
IR
63
5
GME
68
-5
ETN
57
2
NTAP
56
-3
TMO
62
2
HRB
42
-4
D
35
-6
OMC
66
-3
FOX
70
2
CF
41
-7
MNST
59
3
EXR
26
2
HRL
35
12
PNW
55
2
WEC
45
2
ROP
42
4
ETR
49
2
BEN
57
2
LB
33
2
HP
41
3
IR
63
5
GME
68
-5
ETN
57
2
NTAP
56
-3
TMO
62
2
HRB
42
-4
D
35
-6
OMC
66
-3
FOX
70
2
CF
41
-7
MNST
59
3
EXR
26
2
HRL
35
12
PNW
55
2
WEC
45
2
ROP
42
4
ETR
49
2
Financhill
Back

ProShares Ultra Technology Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
62

ROM
ProShares Ultra Technology

Last Price:
$96.00
Seasonality Move:
4.99%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
62
ProShares Ultra Technology (ROM) is a Buy

Is ProShares Ultra Technology a Buy, Sell or Hold?

  • The current ProShares Ultra Technology [ROM] share price is $96.20. The Score for ROM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ROM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ROM Stock Price Chart

What is ProShares Ultra Technology's stock price today?

  • The ProShares Ultra Technology share price today is $96.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ROM is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

ROM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 20.82 Buy
Relative Strength Index (14 RSI): 52.6 Buy
Chaikin Money Flow: -4966 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.33 - 97.87) Buy
Bollinger Bands (100): (83.62 - 98.34) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

ROM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.76 Buy
20-day SMA: 94.85 Buy
50-day SMA: 96.04 Buy
200-day SMA: 77.2 Buy
8-day EMA: 59.31 Buy
20-day EMA: 30.7 Buy
50-day EMA: 13.73 Buy
200-day EMA: 3.64 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

ProShares Ultra Technology Earnings Growth & ROM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

ProShares Ultra Technology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):